INTREXON ACTOBIOTICS N.V.
27Patents
27Active
27Granted
51Portfolio score
Filing activity: Apr 28, 2010 → Sep 8, 2023 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9347036B2 | Modified gram positive bacteria and uses thereof | Emerging Cross-Sectional Technologies | 5 | Active |
| US10905727B2 | Compositions and methods for the treatment of type 1 diabetes | Human Necessities | 4 | Active |
| US9982228B2 | Modified gram positive bacteria and uses thereof | Emerging Cross-Sectional Technologies | 2 | Active |
| US10030234B2 | Modified gram positive bacteria and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US10858663B2 | Genetically modified bacteria stably expressing IL-10 and insulin | Chemistry; Metallurgy | 2 | Active |
| US10808014B2 | Mucoadhesive microorganism | Chemistry; Metallurgy | 2 | Active |
| US11786567B2 | Compositions and methods for the treatment of type 1 diabetes | Human Necessities | 1 | Active |
| US10519418B2 | Modified gram positive bacteria and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US9539291B2 | Induction of mucosal tolerance to antigens | Human Necessities | 1 | Active |
| US11384123B2 | Mucoadhesive microorganism | Chemistry; Metallurgy | 1 | Active |
| US9920324B2 | Polycistronic expression system for bacteria | Chemistry; Metallurgy | 1 | Active |
| US9574169B2 | Cryoprotectants for freeze drying of lactic acid bacteria | Human Necessities | 1 | Active |
| US12359210B2 | Genetically modified bacteria stably expressing IL-10 and insulin | Chemistry; Metallurgy | 0 | Active |
| US10596207B2 | Cryoprotectants for freeze drying of lactic acid bacteria | Human Necessities | 0 | Active |
| US10793825B2 | Modified gram positive bacteria and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10385351B2 | Method to improve Lactococcus preservation | Chemistry; Metallurgy | 0 | Active |
| US10143729B2 | Treatment of immune disease by mucosal delivery of antigens using genetically modified Lactococcus | Chemistry; Metallurgy | 0 | Active |
| US9458467B2 | Modified gram positive bacteria and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9790510B2 | Method to improve Lactococcus preservation | Chemistry; Metallurgy | 0 | Active |
| US10195269B2 | Induction of mucosal tolerance to antigens | Human Necessities | 0 | Active |
| US10668136B2 | Treatment of immune disease by mucosal delivery of antigens using genetically modified Lactococcus | Chemistry; Metallurgy | 0 | Active |
| US9526750B2 | Induction of mucosal tolerance to antigens | Human Necessities | 0 | Active |
| US10988770B2 | Polycistronic expression system for bacteria | Chemistry; Metallurgy | 0 | Active |
| US12252516B2 | Mucoadhesive microorganism | Chemistry; Metallurgy | 0 | Active |
| US11633438B2 | Cryoprotectants for freeze drying of lactic acid bacteria | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.